BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Doxycycline
,
rs2230926
,
IL1A
,
calcium channel activity
,
Breast Cancer
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SN 38 glucuronide
Summary
General Info
Curated Studies
Most Correlated Studies
Colon cancer HT 115 cells expressing UGT1A isoform 2 shRNA and treated with SN-38
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of ir…
Enhancement of CPT-11 antitumor activity by adenovirus-mediated expression of β-glucuronidase in tum…
Pharmacokinetic Assessment of Irinotecan, SN-38, and SN-38-Glucuronide: A Substudy of the FIRIS Stud…
Delayed elimination of SN-38 in cancer patients with severe renal failure.
Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate …
Phase II of BAX2398/5-FU/Calcium Levofolinate in Pancreatic Cancer
For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chem…
Irinotecan in Treating Patients With Advanced Solid Tumors
Combination Chemotherapy in Treating Patients With Colorectal Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ